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apparent mitotic phenotype such as defects in spindle fission yeast enabled us to reach a new stage of analysis
formation, it is possible that Rsp1 is not involved in the of microtubule regulation by capturing the intracellular
reorganization of -TuCs at SPBs or simply that they are motion of -TuC.
not reorganized throughout the cell cycle. Intriguingly, in
budding yeast, mutations in DnaJ (Ydj1p) or in hsp70s Masamitsu Sato and Takashi Toda
caused mitotic spindle defects and abnormally elon- Laboratory of Cell Regulation
gated microtubules upon recovery from microtubule Cancer Research UK
drug nocodazole (Oka et al., 1998). As budding yeast London Research Institute
does not form either eMTOC or postanaphase array of
Lincoln’s Inn Fields Laboratories
microtubules, different organisms might regulate -TuC
London WC2A 3PX
differently. It is of note, however, that the overexpression
United Kingdom
of Rsp1 caused defects in mitotic microtubule organiza-
tion in addition to defects in eMTOC formation, tempting Selected Reading
us into further investigations.
Although eMTOC stays longer in rsp1-1 cells than in Cao, K., Nakajima, R., Meyer, H.H., and Zheng, Y. (2003). Cell
115, 355–367.wild-type, it does not seem to last forever, as persistent
Hagan, I.M. (1998). J. Cell Sci. 111, 1603–1612.eMTOC was not clearly observed in early mitosis. It
might be possible that some other factors are responsi- Hayles, J., and Nurse, P. (2001). Nat. Rev. Mol. Cell Biol. 2, 647–656.
ble for disassembly of eMTOC at mitosis. In Rsp1 over- Heitz, M.J., Petersen, J., Valovin, S., and Hagan, I.M. (2001). J. Cell
Sci. 114, 4521–4532.expression, the formation of eMTOC is inhibited, similar
to some SIN (septation-inducing network; budding yeast Oka, M., Nakai, M., Endo, T., Lim, C.R., Kimata, Y., and Kohno, K.
(1998). J. Biol. Chem. 273, 29727–29737.MEN equivalent) mutants (Heitz et al., 2001; Pardo and
Nurse, 2003). It might be interesting to test the possibility Pardo, M., and Nurse, P. (2003). Science 300, 1569–1574.
that SIN negatively regulates Rsp1 to form eMTOC dur- Sagolla, M.J., Uzawa, S., and Cande, Z. (2003). J. Cell Sci. 116, 4891–
4903.ing anaphase.
Dynamic control of the centrosome is observed in Tran, P.T., Marsh, L., Doye, V., Inoue, S., and Chang, F. (2001). J.
Cell Biol. 153, 397–411.many other organisms, suggesting that this regulation
is of potential importance in the reorganization of micro- Vardy, L., and Toda, T. (2000). EMBO J. 19, 6098–6111.
tubule structure in a broader context, such as develop- Zimmerman, S., Tran, P.T., Daga, R.R., Niwa, O., and Chang, F.
(2004). Dev. Cell 6, this issue, 497–509.mental or differentiation processes. This study using
indicate that ternary complexes of cyclin D-cdk4-p27Stopping and Going with p27kip1
remain catalytically active, so in this “assembly/stabil-
ity” role, p27 would be acting as a positive regulator of
G1 phase progression. Moreover, a current model of G1
Nuclear p27kip1 is an established inhibitor of cyclin- phase cell cycle control argues that sequestration of
dependent kinase-2, and it now appears that cyto- p27 into cyclin D-cdk4 complexes also plays a major
plasmic p27kip1 inhibits the activation of RhoA. In this role in allowing for the activation of cyclin E-cdk2. Yet
dual role, p27kip1 could coordinate cell cycle progres- even with this “new” role, p27 was still regulating G1
sion and cell migration. phase cdk activity.
Some very different ways of thinking about p27 are
beginning to emerge. Several papers link p27 to apopto-p27kip1 (p27) was identified as an inhibitor of cyclin-
sis (Philipp-Staheli et al., 2001), and a growing bodydependent kinase-2 (cdk-2) (Sherr and Roberts, 1999;
of literature is now suggesting that p27 regulates cellPhilipp-Staheli et al., 2001). Downregulation of p27 (of-
motility. Among these studies on cell motility is McAllis-ten through ubiquitin-mediated proteolysis) accompan-
ter et al. (2003), which showed that a cytoplasmic poolies progression through G1 phase and is permissive
of p27 stimulates Rac-dependent migration in HepG2for the periodic activation of cyclin E-cdk2 and cyclin
cells and embryonic fibroblasts; this effect mapped toA-cdk2. The antimitogenic role of p27 was reinforced
a C-terminal domain in p27 and was independent of cdkby the p27-knockout mouse, which is larger than its wild-
inhibitory activity. Cell migration involves the sequentialtype littermate and develops multiorgan hyperplasia as
disassembly and reassembly of focal adhesions, withwell as increased susceptibility to cancer in multiple
focal adhesion turnover at the leading edge allowing fortumor models. A low level of p27 is a marker of poor
cell protrusion. After contraction and translocation of theprognosis in several human adenocarcinomas. All of
cell body, a similar localized turnover of focal adhesionsthese studies fit with the idea that p27 is a straightfor-
allows for retraction of the trailing edge. The Rho familyward inhibitor of G1 phase cell cycle progression, al-
GTPases coordinate these events. Cdc42 stimulatesthough it was somewhat disturbing that p27 levels did
filopodia formation and directed cell movement, Racnot consistently correlate with tumor proliferation.
stimulates lamellipodia formation at the leading edge,A more complex biology for p27 became apparent
and Rho stimulates stress fiber formation and contrac-with the finding that p27 assembles (LaBaer et al., 1997;
tion. The balance between Rac and Rho activities isCheng et al., 1999) or maintains the stability of (Bagui et
al., 2003) cyclin D-cdk4 complexes. Most recent studies thought to play an important role in allowing for cell
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movement because excessive Rho signaling can lead and proliferation play roles in diseases as diverse as
cancer and atherosclerosis, and their relative impor-to an exaggerated adhesion to substratum that inhibits
focal adhesion turnover. The new report by Besson et tance to these diseases is a continuing topic of discus-
sion. If p27 regulates both of these processes, thenal. (2004) shows that p27 titrates the Rho signal.
The authors first confirm previous work (McAllister et perhaps we should think about migration and prolifera-
al., 2003) by documenting the migration defect in p27 tion more as a coordinated set of events. In fact, p27
null mouse embryo fibroblasts (MEFs) and the rescue might coordinate a diverse array of cellular responses
of that defect with p27 or p27CK (a mutant that does through its effect on Rho-dependent cytoskeletal
not inhibit cdks). But they also demonstrate that p27 null structure.
MEFs show increased stress fibers and focal adhesions, There are some discrepancies in the literature with
gold standards of Rho activity which are also overcome regard to p27 and cell migration. This literature is quite
upon expression of p27 or p27CK. Pull-down assays limited, but a few papers indicate that p27 inhibits, rather
showed that loss of p27 increases Rho-GTP levels and than stimulates, cell migration (e.g., see Diez-Juan and
dramatically enhances long-term phosphorylation of Andre´s, 2003). Besson et al. point out that this difference
cofilin, a downstream effector in the Rho pathway. Addi- may simply reflect the amount of Rho (or Rac) activity
tionally, inactivation of Rho kinase (the downstream Rho in different cell types. For example, a p27-dependent
effector that mediates both actin polymerization and inhibition of Rho activation might stimulate migration in
contraction) rescued migration in p27 null MEFs, caus- cells where Rho activity is high yet inhibit migration in
ally linking Rho hyperactivity to the migration defect. cells where Rho activity is moderate. Its also worth not-
Levels of Rac-GTP and Cdc42-GTP were not altered by ing that most of the papers concluding that p27 is a
loss of p27, and no migratory defect was seen in cells migration inhibitor use transwell/Boyden chamber
lacking the closely related cdk inhibitory protein, p21cip1. assays while those showing that p27 stimulates migra-
The overall conclusion is that loss of p27 allows for a tion rely on scattering assays or confluent monolayer
selective activation of Rho, and the resulting increase wounding (scratch) assays. It would not be surprising if
in actin stress fibers and focal adhesions inhibits cell the effect of p27 on cell movement depended upon
motility. cellular context. A debate about the role of p27 as an
Besson et al. then turned to ectopic expression in inhibitor or stimulator of cell migration would be eerily
293T cells to characterize the effect of p27 on RhoA. reminiscent of the debate about how p27 affects cdk4
Overexpression of both proteins allowed the authors to activity. Yes, it seems that we are once again entering
detect a p27-RhoA complex. Consistent with the results new territory and may need to adjust our thinking about
on cell motility, the C-terminal domain (rather than the the biology of p27.
N-terminal cdk inhibitory domain) mediated the interac-
tion with RhoA. Despite overexpression, the interaction
Richard K. Assoianwas specific since a p27-Rac complex was not detect-
Department of Pharmacologyable under similar conditions. Complex formation ap-
University of Pennsylvania School of Medicinepears to be direct based on binding of recombinant p27
Philadelphia, Pennsylvania 19104and RhoA in vitro.
Unlike most Rho-interacting proteins, p27 forms a
Selected Readingcomplex with both activated (63L) and dominant-nega-
tive (N19) RhoA in 293T cells. Since their cell biology Besson, A., Gurian-West, M., Schmidt, A., Hall, A., and Roberts,
indicated that p27 binding to RhoA should have an inhib- J.M. (2004). Genes Dev., in press.
itory function, Besson et al. postulated that complex Bagui, T.K., Mohapatra, S., Haura, E., and Pledger, W.J. (2003). Mol.
formation would attenuate either the activation of RhoA Cell. Biol. 23, 7285–7290.
by its guanine nucleotide exchange factors (GEFs) or Cheng, M., Olivier, P., Diehl, J.A., Fero, M., Roussel, M., Roberts,
the binding of activated RhoA to its effectors. Indeed, J.M., and Sherr, C.J. (1999). EMBO J. 18, 1571–1583.
they found that the binding and activation of RhoA by Diez-Juan, A., and Andre´s, V. (2003). Circ. Res. 92, 402–410.
Rho-specific GEFs was significantly reduced by p27 LaBaer, J., Garrett, M., Stevenson, L., Slingerland, J., Sandhu, C.,
expression while the binding of activated (Q63) RhoA to Chou, H., Fattaey, A., and Harlow, E. (1997). Genes Dev. 11, 847–862.
the Rho binding domain of Rhotekin was unaffected. The McAllister, S.S., Becker-Hapak, M., Pintucci, G., Pagano, M., and
authors therefore propose that p27 acts as a negative Dowdy, S.F. (2003). Mol. Cell. Biol. 23, 216–228.
regulator of migration by directly binding to RhoA and Olson, M.F., Paterson, H.F., and Marshall, C.J. (1998). Nature 394,
inhibiting activation by its GEFs. 295–299.
The temporal and spatial regulation of the interaction Philipp-Staheli, J., Payne, S.R., and Kemp, C.J. (2001). Exp. Cell
Res. 264, 148–168.between endogenous p27 and RhoA will be an intriguing
issue to address with regard to cell movement, but also Sherr, C.J., and Roberts, J.M. (1999). Genes Dev. 13, 1501–1512.
with regard to Rho-dependent effects on the cell cycle Welsh, C.F., Roovers, K., Villanueva, J., Liu, Y., Schwartz, M.A., and
Assoian, R.K. (2001). Nat. Cell Biol. 3, 950–957.(Olson et al., 1998; Welsh et al., 2001). Cell migration
